Research and Development
This group unites PF patients, caregivers, researchers and medical professionals in a platform to... View more
Avalyn Funding to Support Trials of Inhaled Pirfenidone in IPF, CLAD
-
Avalyn Funding to Support Trials of Inhaled Pirfenidone in IPF, CLAD
Avalyn raised $35.5 million to support clinical studies of APO1, aerosolized pirfenidone, to treat IPF and chronic lung allograft dysfunction. Click here to read more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.